Ms Connell is an internationally recognised healthcare and lifesciences leader with investment and licensing expertise. For the past 20 years, Kathy has held senior executive leadership positions in biotechnology, pharmaceutical, medical device and consumer health sectors in business development, licensing, acquisitions and venture investment, including 12 years at Johnson & Johnson as Senior Director, New Ventures ANZ. Kathy co-founded Medicines Australias Pharmaceutical Australia Inclusion Group (PAIG) - a working group designed to foster diverse and inclusive corporate cultures across the pharmaceutical industries. Today Kathy leads Korn Ferrys Healthcare and LifeSciences practice in Australia as Senior Client Partner and she is also a Non-Executive Director of BioNSW.
Katherine(Kathy) Connell
Non-Executive Director / Avecho Biotechnology